Novo Nordisk

United States, Plainsboro
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Novo Nordisk employs approximately 41,500 employees in 75 countries, and markets its products in more than 180 countries.

Within our R&D... interest areas Diabetes and its complications, Obesity, NASH, Cardiovascular Disease (CVD), Kidney Disease, Haemophilia, Growth Hormone therapies, and Protein Technologies and Delivery, we seek innovative technologies and biologics projects at all stages of development - from early discovery to clinical phases. For further information on our current interests see:


Main sector Pharma
Subsector Drug delivery, Peptides, Proteins